Relationship Between Aspirin Metabolism and Markers of Metabolic Dysfunction Among Pregnant Persons at Risk of Pre-eclampsia
NCT06802861 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2025-09-10
Summary
This study's primary purpose is to determine the relationship between aspirin metabolism and markers of metabolic dysfunction among patients at risk for preeclampsia.
Conditions
- Preeclampsia
- Preeclampsia (PE)
- Preeclampsia (PE) Risk
- Obesity and Obesity-related Medical Conditions
- Pregnancy
- Pregnancy Complications
- Gestational Diabetes
- Gestational Diabetes Mellitus in Pregnancy
- Gestational Complications
Sponsors & Collaborators
-
University of Tennessee Graduate School of Medicine
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2026-07-31
- Completion
- 2028-12-31
Countries
- United States
Study Locations
More Related Trials
-
Aspirin (ASA) Therapy and Preeclampsia Prevention
NCT04158830 ·Status: WITHDRAWN ·Phase: PHASE4
-
Predictors of Aspirin Failure in Preeclampsia Prevention
NCT05709483 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Aspirin for Prevention of Preeclampsia
NCT03726177 ·Status: UNKNOWN ·Phase: NA
-
Aspirin Versus Metformin in Pregnancies at High Risk of Preterm Preeclampsia: a 3-arm Randomized Controlled Trial
NCT05580523 ·Status: RECRUITING ·Phase: NA
-
The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population
NCT05089175 ·Status: UNKNOWN
-
Aspirin to Prevent Preeclampsia in Women With Elevated Blood Pressure and Stage 1 Hypertension (ASPPIRE)
NCT04402385 ·Status: TERMINATED ·Phase: PHASE2
-
Role of ASpirin in Placental and Maternal Endothelial Cell Regulation IN Pre-eclampsia
NCT03893630 ·Status: COMPLETED ·Phase: PHASE2
-
Early Prediction and Randomised Prevention of Preeclampsia With Low Dose Aspirin in Chinese Cohort
NCT04631627 ·Status: UNKNOWN ·Phase: PHASE4
-
Antenatal Platelet Response On Aspirin and Correlation With HDP (Hypertensive Disorders of Pregnancy)
NCT04295850 ·Status: COMPLETED
-
Low Dose Aspirin for the Prevention of Preeclampsia
NCT01890005 ·Status: UNKNOWN ·Phase: PHASE3
-
Aspirin 150 mg vs 100 mg for Prevention of Preeclampsia in High-Risk Obese Pregnant Women
NCT06952712 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Daily Aspirin Treatment After Preeclampsia
NCT06168461 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Prenatal Aspirin and Postpartum Vascular Function
NCT05653973 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Aspirin for the Prevention of Preeclampsia in Women With Stage 1 Hypertension
NCT04908982 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment With Aspirin After Preeclampsia: TAP Trial
NCT06281665 ·Status: RECRUITING ·Phase: PHASE4
-
Utilization of Aspirin for Prevention of Pre-Eclampsia in Nigeria: A Explanatory Sequential Mixed Methods Study
NCT06053203 ·Status: COMPLETED
-
162 mg of Aspirin for Prevention of Preeclampsia
NCT05221164 ·Status: UNKNOWN ·Phase: PHASE4
-
Low Dose Aspirin in the Prevention of Preeclampsia in China
NCT02797249 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
NCT06468202 ·Status: RECRUITING ·Phase: PHASE4
-
Immunomodulation During Pregnancy
NCT06882850 ·Status: RECRUITING
-
Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers
NCT01729468 ·Status: COMPLETED ·Phase: PHASE4
-
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
NCT06826859 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Aspirin and Preeclampsia
NCT04479072 ·Status: RECRUITING ·Phase: PHASE4
-
Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia
NCT04797949 ·Status: WITHDRAWN ·Phase: PHASE4
-
Aspirin for the Prevention of Preeclampsia and Pregnancy Outcomes After Assisted Reproductive Technology
NCT05625724 ·Status: RECRUITING ·Phase: PHASE3